Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:cancer
|
| gptkbp:administeredAtHome |
true
|
| gptkbp:alsoKnownAs |
TTFields
|
| gptkbp:approvalYear |
2011
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:glioblastoma mesothelioma |
| gptkbp:clinicalTrialPhase |
EF-14
|
| gptkbp:compatibleWith |
benign tumors
|
| gptkbp:contraindication |
metal implants in head
pacemaker |
| gptkbp:deliveredBy |
transducer arrays
|
| gptkbp:developedBy |
gptkb:Novocure
|
| https://www.w3.org/2000/01/rdf-schema#label |
tumor-treating fields
|
| gptkbp:increasesSurvival |
glioblastoma patients
|
| gptkbp:mechanismOfAction |
disrupts cancer cell division
|
| gptkbp:noninvasive |
true
|
| gptkbp:requiresShavedScalp |
true
|
| gptkbp:sideEffect |
skin irritation
|
| gptkbp:usedFor |
gptkb:temozolomide
|
| gptkbp:uses |
low-intensity alternating electric fields
|
| gptkbp:bfsParent |
gptkb:glioblastoma_multiforme
|
| gptkbp:bfsLayer |
6
|